Clarion Medicals Limited Pharmaceutical Import Profile — Nigeria (DGFT 2022–2026)

Name: Clarion Medicals Limited Pharmaceutical Import Records from India — 2 Products, $450.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Clarion Medicals Limited — Pharmaceutical Importer Profile (2026) | 2 Products, $450.0K Trade | TransData Nexus

Clarion Medicals Limited

Pharmaceutical Importer · Nigeria · Advanced Antibiotics Focus · $450.0K Total Trade · DGFT Verified

Clarion Medicals Limited is a pharmaceutical importer based in Nigeria with a total trade value of $450.0K across 2 products in 2 therapeutic categories. Based on 9 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Clarion Medicals Limited sources from 3 verified Indian suppliers, with The Madras Pharmaceuticals accounting for 76.7% of imports.

Clarion Medicals Limited — Import Portfolio & Supplier Network

Clarion Medicals Limited import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Clarion Medicals Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
The Madras Pharmaceuticals	$824.2K	30	76.7%
Inject Care Parenterals Private Limited	$200.0K	4	18.6%
Makcur Laboratories Limited	$50.0K

What Formulations Does Clarion Medicals Limited Import?

Formulation	Value	Ships
Aday kit tablet (fluconazole USP 150 MG,azithromycin USP 1g, secnidazole 2g)	$105.2K	3
Tab.glucocare tablets (glimepiride USP	$100.0K	2
Glucocare tablet (glimepride USP 1MG & metformin hydrochloride BP 1000 MG sr tablets)	$100.0K	2
Fortified procaine penicillin injection4	$50.0K	1
Tab.aday kit fluconazole USP 150 MG	$50.0K	1
Tab.aday kit fluconazoleusp 150 MG azithromycin usup 1g secnidazole 2g	$50.0K	1
Arthris forte glucosamine chondrotin and methyl sulfonyl methane with vitamin e& minerals 3x10s	$50.0K	1
Arthris forte glucosamine chondrotin and methyl sulfonyl methane with vitamin e& minerals 1x30s	$50.0K	1
Moxitin injection 500mgcombipack of amoxicillin sodium for injection BP 500mgsterilised water for injectionsbp 5ML	$50.0K	1
Arthris forte glucosamine chondrotin and methyl sulfonyl methane with vitamine &	$50.0K	1
Arthris forte glucosamine chondrotin and methyl sulfonyl methane with vitamine &	$50.0K	1
Aday kitfluconazole USP 150 MG azithromycin USP 1g secnidazole 2g	$50.0K	1
Drug formulations injections (ampules /vials above 10 ML) fortified procaine penicillin for injection 4 mega claripen	$50.0K	1
Fortified procaine penicilin 4 mega injection BP (claripen - forte injection) (690000vials	$50.0K	1
Fortified procaine penicillin injection4 mega (claripen - forte injection) (690000 vials)	$50.0K	1

Clarion Medicals Limited imports 24 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Secnidazole	Advanced Antibiotics	$250.0K	5	0.8%	8
2	Glucosamine	Nutritional Supplements	$200.0K	4	1.5%	9

Clarion Medicals Limited imports 2 pharmaceutical products across 2 categories into Nigeria totaling $450.0K.

Clarion Medicals Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Clarion Medicals Limited is a Nigerian pharmaceutical company established in 1997, specializing in the importation and distribution of finished pharmaceutical formulations. Headquartered in Lagos, Nigeria, the company has expanded its operations to include offices in London and Dubai, reflecting its growing international presence. Clarion Medicals is committed to providing superior and innovative products for the prevention and treatment of various health conditions, aiming to improve the overall well-being of individuals.

The company's product portfolio encompasses a range of therapeutic areas, including antimalarial treatments, antibiotics, antidiabetics, anti-hypertensives, and haematinics. These products are designed to address diverse health needs, such as disease prevention and the treatment of ailments. Clarion Medicals Limited operates as a pharmaceutical importer and distributor, playing a significant role in Nigeria's pharmaceutical supply chain by ensuring the availability of essential medications to meet the country's healthcare demands.

2Distribution Network

Clarion Medicals Limited's distribution network is strategically designed to ensure efficient delivery of pharmaceutical products across Nigeria. The company's primary warehouse is located in Lagos, serving as the central hub for storage and distribution. This centralization facilitates streamlined logistics and inventory management, enabling the company to meet the demands of various regions within Nigeria effectively. While specific details about additional warehouse locations or logistics capabilities are not publicly disclosed, the company's established presence in major Nigerian cities suggests a well-developed distribution infrastructure.

3Industry Role

In Nigeria's pharmaceutical supply chain, Clarion Medicals Limited functions as a pharmaceutical importer and distributor. By sourcing finished pharmaceutical formulations from international suppliers, particularly from India, the company ensures the availability of a diverse range of medications within the Nigerian market. This role is crucial in bridging the gap between global pharmaceutical manufacturers and local healthcare providers, thereby contributing to the overall health infrastructure of Nigeria.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Clarion Medicals Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Clarion Medicals Limited's sourcing strategy exhibits a notable concentration on a select group of suppliers. The company's total import value from India amounts to $450,000 USD, distributed across nine shipments. The top five imported products include Secnidazole ($250,000 USD) and Glucosamine ($200,000 USD), accounting for 0.8% and 1.5% of the total import value, respectively. This concentration indicates a strategic focus on specific therapeutic areas, particularly advanced antibiotics and nutritional supplements.

The supplier base comprises three unique Indian suppliers:

The Madras Pharmaceuticals: $824,000 USD (30 shipments, 76.7%)
Inject Care Parenterals Private Limited: $200,000 USD (4 shipments, 18.6%)
Makcur Laboratories Limited: $50,000 USD (1 shipment, 4.7%)

This supplier distribution suggests a primary reliance on The Madras Pharmaceuticals, with a significant majority of shipments sourced from this supplier. While such concentration can lead to favorable terms and streamlined operations, it also poses risks related to supply chain disruptions. Diversifying the supplier base could mitigate potential vulnerabilities and enhance supply chain resilience.

Supply Chain Resilience

Importing Pharmaceuticals into Nigeria — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Nigeria

1Regulatory Authority & Framework

In Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC) serves as the primary regulatory authority overseeing the importation, distribution, and marketing of pharmaceutical products. NAFDAC is responsible for ensuring that all pharmaceutical products meet established safety, efficacy, and quality standards before they are permitted for sale in the Nigerian market. The agency operates under the National Agency for Food and Drug Administration and Control Act Cap N1, Laws of the Federation of Nigeria (LFN), 2004. (freyrsolutions.com.ng)

Key legislation governing pharmaceutical imports into Nigeria includes the NAFDAC Act, which outlines the regulatory framework for drug registration, importation, and distribution. Additionally, the Pharmaceutical Council of Nigeria (PCN) regulates the professional practices of pharmacists involved in drug distribution and pharmaceutical regulatory affairs in Nigeria. These regulatory bodies collaborate to ensure that imported pharmaceutical products adhere to the required standards and are safe for public use. (freyrsolutions.com.ng)

2Import Licensing & GMP

Import licensing requirements in Nigeria stipulate that pharmaceutical products must be registered with NAFDAC before importation. This process involves submitting an application for product registration, which includes providing evidence of Good Manufacturing Practice (GMP) certification from the manufacturing facility. NAFDAC recognizes GMP certifications from reputable international bodies, such as the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). This recognition ensures that imported pharmaceutical products meet international quality standards. (freyrsolutions.com.ng)

Clarion Medicals Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Clarion Medicals Limited's product strategy focuses on therapeutic areas that address prevalent health concerns in Nigeria. The company's emphasis on antimalarial treatments, antibiotics, antidiabetics, anti-hypertensives, and haematinics aligns with the country's healthcare priorities, targeting diseases such as malaria, infections, diabetes, hypertension, and anemia. This strategic focus is driven by market demand for effective and affordable treatments in these areas, positioning Clarion Medicals as a key player in meeting the healthcare needs of the Nigerian population.

2Sourcing Profile

Clarion Medicals Limited's sourcing strategy is centered on importing finished pharmaceutical formulations from India, a country known for its robust pharmaceutical manufacturing sector. The company's preference for finished products over active pharmaceutical ingredients (APIs) indicates a focus on ready-to-market solutions that can be quickly distributed within Nigeria. This approach allows Clarion Medicals to leverage India's manufacturing capabilities while ensuring compliance with Nigerian regulatory standards. (freyrsolutions.com.ng)

3Market Positioning

Frequently Asked Questions — Clarion Medicals Limited

What products does Clarion Medicals Limited import from India?

Clarion Medicals Limited imports 2 pharmaceutical products across 2 categories. Top imports: Secnidazole ($250.0K), Glucosamine ($200.0K).

Who supplies pharmaceuticals to Clarion Medicals Limited from India?

Clarion Medicals Limited sources from 3 verified Indian suppliers. The primary supplier is The Madras Pharmaceuticals (76.7% of imports, $824.2K).

What is Clarion Medicals Limited's total pharmaceutical import value?

Clarion Medicals Limited's total pharmaceutical import value from India is $450.0K, based on 9 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Clarion Medicals Limited focus on?

Clarion Medicals Limited imports across 2 categories. The largest: Advanced Antibiotics (55.6%), Nutritional Supplements (44.4%).

Get Full Clarion Medicals Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.